Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zicam Creates A Monster With Reanimated Brand

This article was originally published in The Tan Sheet

Executive Summary

Matrixx aims to make more consumers aware they can shorten the duration of a cold rather than treat the symptoms without affecting how long the cold lasts. New advertising introduces the “Cold Monster” to remind consumers to use Zicam products when they feel the first signs of a “monster of a cold.”

Advertisement

Related Content

Reformulated Zicam Nasal Swabs Return Matrixx To Top Sales Category
Reformulated Zicam Nasal Swabs Return Matrixx To Top Sales Category
Matrixx Keeps “Pre-Cold” With NAD Ad Victory
Matrixx Keeps “Pre-Cold” With NAD Ad Victory
Matrixx Zicam “Cold Monster” Campaign Claims Fail NAD Test
Matrixx Zicam “Cold Monster” Campaign Claims Fail NAD Test
Cold-EEZE Claims Chilled By Zicam Maker’s NAD Challenge
Cold-EEZE Claims Chilled By Zicam Maker’s NAD Challenge
Matrixx Appoints Scerene Healthcare Executive To Lead Turnaround
Zicam Maker Matrixx' Sales Plummet While Legal Costs Climb

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106045

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel